Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes-Reference-Cited by-同舟云学术

Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes

Published:2021-09-27 Issue:10 Volume:6 Page:1309-1318
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Aggarwala Varun,Mogno Ilaria,Li Zhihua,Yang Chao,Britton Graham J.^ORCID,Chen-Liaw Alice,Mitcham Josephine,Bongers Gerold,Gevers Dirk,Clemente Jose C.^ORCID,Colombel Jean-Frederic,Grinspan Ari,Faith Jeremiah^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

https://www.nature.com/articles/s41564-021-00966-0.pdf

Reference51 articles.

1. Ooijevaar, R. E., Terveer, E. M., Verspaget, H. W., Kuijper, E. J. & Keller, J. J. Clinical application and potential of fecal microbiota transplantation. Annu. Rev. Med. 70, 335–351 (2019).

2. van Nood, E., Dijkgraaf, M. G. W. & Keller, J. J. Duodenal infusion of feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 2145 (2013).

3. Kelly, C. R. et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection a randomized trial. Ann. Intern. Med. 165, 609–616 (2016).

4. Smillie, C. S. et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe 23, 229–240.e5 (2018).

5. Li, S. S. et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352, 586–589 (2016).

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergent metabolic interactions in resistance toClostridioides difficileinvasion;2024-08-30

2. StrainR2 accurately deconvolutes strain-level abundances in synthetic microbial communities;2024-08-09

3. Microbiome modification for personalized treatment of dysbiotic diseases;Cell Host & Microbe;2024-08

4. Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment;Pathogens;2024-07-31

5. Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways;Current Hepatology Reports;2024-07-29